Illegal Use of Endangered Animal Parts by Three Chinese Firms Exposed

Three publicly traded Chinese drugmakers, including Beijing Tong Ren Tang group, Tianjin Pharmaceutical group, and Jilin Aodong Pharmaceutical Group, have been found to use parts of endangered animals as ingredients in their products, according to a report by the Environmental Investigation Agency. The report highlights 72 firms that use body parts of threatened leopards and pangolins in at least 88 traditional Chinese medicine (TCM) products. The NGO urges global investors, including major banks and financial institutions, to divest from these companies. The Chinese government is called upon to prohibit the use of endangered animal parts for commercial purposes.